Xenon Pharmaceuticals Inc.
Quick facts
| Founded | 1996 |
|---|
Phase 3 pipeline
- XEN1101 · Pain
XEN1101 is a selective Nav1.7 sodium channel blocker.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Xenon Pharmaceuticals Inc.
What is Xenon Pharmaceuticals Inc.'s pipeline?
Xenon Pharmaceuticals Inc. has 1 drugs in Phase 3, 2 in Phase 2, 6 in Phase 1. Late-stage candidates include XEN1101.
When was Xenon Pharmaceuticals Inc. founded?
Xenon Pharmaceuticals Inc. was founded in 1996.
Related
- Sector hub: All tracked pharma companies